Literature DB >> 15084612

The treatment of stages I-IV favorable histology Wilms' tumor.

Daniel M Green1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15084612     DOI： 10.1200/JCO.2004.08.008

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  33 in total

1.  Considerations in the Diagnosis and Management of Pediatric Patients With Favorable Histology Wilms Tumor Who Present With Only Pulmonary Nodules.

Authors:  Daniel M Green
Journal:  Pediatr Blood Cancer       Date:  2015-12-02       Impact factor: 3.167

2.  Late recurrence of Wilms' tumour with exclusive skeletal muscle phenotype 23 years after primary diagnosis.

Authors:  Rebecca Senetta; Luigia Macrì; Donatella Pacchioni; Isabella Castellano; Paola Cassoni; Gianni Bussolati
Journal:  Virchows Arch       Date:  2006-11-17       Impact factor: 4.064

3.  Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

Authors:  David B Dix; Nita L Seibel; Yueh-Yun Chi; Geetika Khanna; Eric Gratias; James R Anderson; Elizabeth A Mullen; James I Geller; John A Kalapurakal; Arnold C Paulino; Elizabeth J Perlman; Peter F Ehrlich; Marcio Malogolowkin; Julie M Gastier-Foster; Elizabeth Wagner; Paul E Grundy; Conrad V Fernandez; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2018-04-16       Impact factor: 44.544

4.  Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008.

Authors:  Vikram Jairam; Kenneth B Roberts; James B Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-12-27       Impact factor: 7.038

5.  Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.

Authors:  Peter F Ehrlich; James R Anderson; Michael L Ritchey; Jeffrey S Dome; Daniel M Green; Paul E Grundy; Elizabeth J Perlman; John A Kalapurakal; Norman E Breslow; Robert C Shamberger
Journal:  J Clin Oncol       Date:  2013-02-04       Impact factor: 44.544

6.  CITED1 expression in Wilms' tumor and embryonic kidney.

Authors:  Harold N Lovvorn; Jenifer Westrup; Shaun Opperman; Scott Boyle; Genbin Shi; James Anderson; Elizabeth J Perlman; Alan O Perantoni; Marcia Wills; Mark de Caestecker
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

Review 7.  Children's Oncology Group's 2013 blueprint for research: renal tumors.

Authors:  Jeffrey S Dome; Conrad V Fernandez; Elizabeth A Mullen; John A Kalapurakal; James I Geller; Vicki Huff; Eric J Gratias; David B Dix; Peter F Ehrlich; Geetika Khanna; Marcio H Malogolowkin; James R Anderson; Arlene Naranjo; Elizabeth J Perlman
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

8.  Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.

Authors:  Najat C Daw; David Gregornik; John Rodman; Neyssa Marina; Jianrong Wu; Larry E Kun; Jesse J Jenkins; Valerie McPherson; Judith Wilimas; Deborah P Jones
Journal:  Eur J Cancer       Date:  2008-11-06       Impact factor: 9.162

9.  Management of Wilms' tumor: NWTS vs SIOP.

Authors:  Sushmita Bhatnagar
Journal:  J Indian Assoc Pediatr Surg       Date:  2009-01

10.  Portal hypertension in children with Wilms' tumor: a report from the National Wilms' Tumor Study Group.

Authors:  Anne B Warwick; John A Kalapurakal; San-San Ou; Daniel M Green; Pat A Norkool; Susan M Peterson; Norman E Breslow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-19       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.